Omnicom Group relationship marketing agency Unit 7 has picked up new accounts from two pharma clients, the firm’s CEO Loreen Babcock told MM&M.
In July, it was named consumer agency for Shire’s Daytrana attention deficit disorder patch, approved by the FDA in April and made available in pharmacies in late June. The firm will also do advertising and relationship marketing work for the launch of another undisclosed Shire brand, according to Babcock.
Unit 7 has also been awarded a global brand position and launch assignment from Bayer’s diagnostics division, expected to appear in 2007.
From the August 01, 2006 Issue of MM+M - Medical Marketing and Media
